Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
May 11, 2023 at 04:02 pm EDT
Share
Applied DNA Sciences, Inc. reported earnings results for the second quarter and six months ended March 31, 2023. For the second quarter, the company reported revenue was USD 4.41 million compared to USD 6.15 million a year ago. Net income was USD 0.588343 million compared to net loss of USD 1.76 million a year ago. Basic earnings per share from continuing operations was USD 1 compared to basic loss per share from continuing operations of USD 4.6 a year ago. Diluted earnings per share from continuing operations was USD 1 compared to diluted loss per share from continuing operations of USD 4.6 a year ago.
For the six months, revenue was USD 9.67 million compared to USD 10.31 million a year ago. Net loss was USD 3.26 million compared to USD 6.48 million a year ago. Basic loss per share from continuing operations was USD 5 compared to USD 17 a year ago. Diluted loss per share from continuing operations was USD 5 compared to USD 17 a year ago.
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Companyâs proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Companyâs Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
APPLIED DNA SCIENCES, INC. 
